289 related articles for article (PubMed ID: 18759303)
1. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis.
Guiducci S; Distler JH; Jüngel A; Huscher D; Huber LC; Michel BA; Gay RE; Pisetsky DS; Gay S; Matucci-Cerinic M; Distler O
Arthritis Rheum; 2008 Sep; 58(9):2845-53. PubMed ID: 18759303
[TBL] [Abstract][Full Text] [Related]
2. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
[TBL] [Abstract][Full Text] [Related]
3. Decreased lymphatic vessel counts in patients with systemic sclerosis: association with fingertip ulcers.
Akhmetshina A; Beer J; Zwerina K; Englbrecht M; Palumbo K; Dees C; Reich N; Zwerina J; Szucs G; Gusinde J; Nevskaya T; Distler O; Kerjaschki D; Schett G; Distler JH
Arthritis Rheum; 2010 May; 62(5):1513-22. PubMed ID: 20155824
[TBL] [Abstract][Full Text] [Related]
4. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity.
Avouac J; Juin F; Wipff J; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
Ann Rheum Dis; 2008 Oct; 67(10):1455-60. PubMed ID: 18174219
[TBL] [Abstract][Full Text] [Related]
5. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.
Del Papa N; Colombo G; Fracchiolla N; Moronetti LM; Ingegnoli F; Maglione W; Comina DP; Vitali C; Fantini F; Cortelezzi A
Arthritis Rheum; 2004 Apr; 50(4):1296-304. PubMed ID: 15077314
[TBL] [Abstract][Full Text] [Related]
6. Plasma endothelial microparticles reflect the extent of capillaroscopic alterations and correlate with the severity of skin involvement in systemic sclerosis.
Michalska-Jakubus M; Kowal-Bielecka O; Smith V; Cutolo M; Krasowska D
Microvasc Res; 2017 Mar; 110():24-31. PubMed ID: 27889559
[TBL] [Abstract][Full Text] [Related]
7. Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis.
Manetti M; Neumann E; Müller A; Schmeiser T; Saar P; Milia AF; Endlicher E; Roeb E; Messerini L; Matucci-Cerinic M; Ibba-Manneschi L; Müller-Ladner U
Arthritis Rheum; 2008 Sep; 58(9):2866-73. PubMed ID: 18759276
[TBL] [Abstract][Full Text] [Related]
8. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
9. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients.
Giacomelli R; Matucci-Cerinic M; Cipriani P; Ghersetich I; Lattanzio R; Pavan A; Pignone A; Cagnoni ML; Lotti T; Tonietti G
Arthritis Rheum; 1998 Feb; 41(2):327-34. PubMed ID: 9485091
[TBL] [Abstract][Full Text] [Related]
10. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
[TBL] [Abstract][Full Text] [Related]
11. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
12. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
Allanore Y; Borderie D; Lemaréchal H; Cherruau B; Ekindjian OG; Kahan A
J Rheumatol; 2003 Jan; 30(1):68-73. PubMed ID: 12508392
[TBL] [Abstract][Full Text] [Related]
13. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietins-1 and -2 are differentially expressed in the sera of patients with systemic sclerosis: high angiopoietin-2 levels are associated with greater severity and higher activity of the disease.
Michalska-Jakubus M; Kowal-Bielecka O; Chodorowska G; Bielecki M; Krasowska D
Rheumatology (Oxford); 2011 Apr; 50(4):746-55. PubMed ID: 21149250
[TBL] [Abstract][Full Text] [Related]
15. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
16. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes.
Matsushita T; Hasegawa M; Yanaba K; Kodera M; Takehara K; Sato S
Arthritis Rheum; 2006 Jan; 54(1):192-201. PubMed ID: 16385515
[TBL] [Abstract][Full Text] [Related]
18. Elevated vascular endothelial growth factor in systemic sclerosis.
Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of circulating endothelial and platelet microparticles in men with ankylosing spondylitis.
Sari I; Bozkaya G; Kirbiyik H; Alacacioglu A; Ates H; Sop G; Can G; Taylan A; Piskin O; Yildiz Y; Akkoc N
J Rheumatol; 2012 Mar; 39(3):594-9. PubMed ID: 22247348
[TBL] [Abstract][Full Text] [Related]
20. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.
Diehl P; Aleker M; Helbing T; Sossong V; Beyersdorf F; Olschewski M; Bode C; Moser M
Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):133-7. PubMed ID: 20472650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
